Kakinuma T, Kaneko A, Kakinuma K, Matsuda Y, Yanagida K, Takeshima N, Ohwada M. Effectiveness of treating menorrhagia using microwave endometrial ablation at a frequency of 2.45 GHz. World J Clin Cases 2023; 11(24): 5653-5659 [PMID: 37727709 DOI: 10.12998/wjcc.v11.i24.5653]
Corresponding Author of This Article
Toshiyuki Kakinuma, MD, PhD, Professor, Department of Obstetrics and Gynecology, International University of Health and Welfare Hospital, 537-3, Iguchi, Nasushiobara 329-2763, Japan. tokakinuma@gmail.com
Research Domain of This Article
Obstetrics & Gynecology
Article-Type of This Article
Retrospective Cohort Study
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Share the Article
Kakinuma T, Kaneko A, Kakinuma K, Matsuda Y, Yanagida K, Takeshima N, Ohwada M. Effectiveness of treating menorrhagia using microwave endometrial ablation at a frequency of 2.45 GHz. World J Clin Cases 2023; 11(24): 5653-5659 [PMID: 37727709 DOI: 10.12998/wjcc.v11.i24.5653]
Toshiyuki Kakinuma, Ayaka Kaneko, Kaoru Kakinuma, Yoshio Matsuda, Kaoru Yanagida, Nobuhiro Takeshima, Michitaka Ohwada, Department of Obstetrics and Gynecology, International University of Health and Welfare Hospital, Nasushiobara 329-2763, Japan
Author contributions: Kakinuma T contributed to conceptualization, methodology, software, validation, original draft preparation, manuscript review and editing, visualization, supervision, and project administration; all authors contributed to formal analysis, investigation, resources, and data curation; all authors have read and agreed to the published version of the manuscript.
Institutional review board statement: This study was approved by the Ethics Committee of the International University of Health and Welfare (approval number, 20-B-399; approval date, May 7, 2020).
Informed consent statement: All patients provided written and verbal informed consent for study participation.
Conflict-of-interest statement: All the authors have no conflict of interest related to the manuscript.
Data sharing statement: All data generated or analyzed during this study are included in this published article.
STROBE statement: The authors have read the STROBE Statement—checklist of items, and the manuscript was prepared and revised according to the STROBE Statement—checklist of items.
Corresponding author: Toshiyuki Kakinuma, MD, PhD, Professor, Department of Obstetrics and Gynecology, International University of Health and Welfare Hospital, 537-3, Iguchi, Nasushiobara 329-2763, Japan. tokakinuma@gmail.com
Received: April 14, 2023 Peer-review started: April 14, 2023 First decision: July 7, 2023 Revised: July 17, 2023 Accepted: August 3, 2023 Article in press: August 3, 2023 Published online: August 26, 2023 Processing time: 132 Days and 21.9 Hours
ARTICLE HIGHLIGHTS
Research background
Microwave endometrial ablation (MEA) is a minimally invasive treatment for menorrhagia. It has been covered by the national insurance in Japan, and its demand has been increasing as the importance of women’s health has advanced in society.
Research motivation
MEA was introduced as a treatment option for menorrhagia at our hospital in January 2016.
Research objectives
This retrospective study aimed to clinically examine cases in which MEA was performed for menorrhagia at our hospital.
Research methods
We retrospectively analyzed 76 patients who underwent MEA between January 2016 and March 2020 in our department.
Research results
The visual analog scale scores of menorrhagia and menstrual pain showed improvements after MEA. The hemoglobin levels significantly improved after MEA. Endometritis was observed in only one patient after surgery and was treated with antibiotics.
Research conclusions
MEA is a safe and effective treatment for menorrhagia.
Research perspectives
MEA could be a useful option for the treatment of menorrhagia in patients who are at high risk for hysterectomy due to complications or comorbidities, or who desire minimally invasive surgery.
